Ridgepath Capital Management’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$439K Buy
7,103
+762
+12% +$46K 0.19% 37
2026
Q1
$371K Buy
6,341
+84
+1% +$4.97K 0.18% 42
2025
Q4
$332K Hold
6,257
0.15% 34
2025
Q3
$332K Hold
6,257
0.14% 36
2025
Q2
$296K Hold
6,257
0.14% 36
2025
Q1
$259K Hold
6,257
0.12% 43
2024
Q4
$227K Sell
6,257
-680
-10% -$24.6K 0.1% 42
2024
Q3
$254K Buy
+6,937
New +$248K 0.2% 38
2024
Q2
Sell
-6,937
Closed -$212K 44
2024
Q1
$212K Buy
+6,937
New +$209K 0.24% 42

Other funds holding BTI

Ridgepath Capital Management's BTI Position: Q2 2026 in Review

Ridgepath Capital Management increased its British American Tobacco (BTI) stake by 12% in Q2 2026, buying an estimated $46K and bringing the position to 7,103 shares worth $439K. The position accounts for 0.19% of the portfolio, ranked #37.

Ridgepath Capital Management first reported a position in BTI in Q1 2024 and has held it in 9 quarters since. 907 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Ridgepath Capital Management held 7,103 shares of British American Tobacco worth $439K as of Q2 2026.
  • Ridgepath Capital Management bought 762 British American Tobacco shares in Q2 2026, an estimated $46K.
  • British American Tobacco made up 0.19% of Ridgepath Capital Management's portfolio in Q2 2026, its #37 holding.
  • Ridgepath Capital Management first reported a position in British American Tobacco in Q1 2024 and has held it in 9 quarters since.
  • 907 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Ridgepath Capital Management's 13F filing for Q2 2026, filed 20 Aug 2026.